Form 3: MDT Director Groetelaars Declares Zero Beneficial Ownership

Rhea-AI Filing Summary

John P. Groetelaars filed an initial Form 3 reporting his relationship to Medtronic plc (MDT) as a Director and stating that he does not beneficially own any ordinary shares as of the event date 08/19/2025. The filing indicates it was submitted by one reporting person and was signed on behalf of Groetelaars by an attorney-in-fact, Patricia Walesiewicz. The form fulfills Section 16(a) reporting requirements for an insider initial ownership statement and contains an explicit declaration that no securities are beneficially owned.

Positive

• Timely Section 16 disclosure filed for a director
• Explicit statement of zero beneficial ownership, clarifying insider holdings status

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine insider disclosure showing no stock holdings by a newly reported director; immaterial to Medtronic's financials.

This Form 3 is a standard initial Section 16 filing noting director status and zero beneficial ownership of Medtronic ordinary shares as of 08/19/2025. From a financial perspective, the disclosure contains no transaction, no grant, and no change to share count or dilution. It does not affect earnings, cash flows, or ownership metrics and therefore carries no direct valuation implications.

Corporate Governance Expert

TL;DR: Governance disclosure completed; absence of holdings is noted and filing appears properly executed by attorney-in-fact.

The filing identifies Groetelaars as a director and confirms compliance with initial beneficial ownership reporting obligations. The signature by an attorney-in-fact is explicitly recorded. While useful for transparency, the absence of any reported equity interest or derivative positions means there are no governance conflicts or related-party equity concerns disclosed here.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Groetelaars John P

(Last) (First) (Middle)

C/O MEDTRONIC

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2025

3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	0(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. No securities are beneficially owned.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John P. Groetelaars report on Form 3 for MDT?

The Form 3 reports that Groetelaars is a Director of Medtronic plc and does not beneficially own any ordinary shares as of 08/19/2025.

When is the event date reported on the Form 3?

The date of the event requiring the statement is 08/19/2025.

Who signed the Form 3 for Groetelaars?

The filing was signed by Patricia Walesiewicz, attorney-in-fact on 08/19/2025.

Does this Form 3 disclose any derivative securities or options?

No. The filing shows no non-derivative or derivative securities beneficially owned by the reporting person.

Is this filing by one person or multiple reporting persons?

The form indicates it was filed by one reporting person.